# CDT Equity Inc. (CDTTW) — merger/scheme_of_arrangement [announced]
Source: SEC API (secapi.ai) · situation sit_9eb669154d754d211dc8 · retrieved 2026-08-11T15:50:48.130Z

## Overview
CDT Equity Inc. is a Delaware corporation engaged in acquiring equity interests in other companies; it previously operated as Conduit Pharmaceuticals Inc. and Murphy Canyon Acquisition Corp.

On July 30, 2026, CDT Equity Inc. entered into a Securities Purchase Agreement with stockholders of Sarborg Limited (a Cayman Islands company) to acquire 270 shares of Sarborg, representing approximately 4.76% of Sarborg's outstanding common stock. In exchange, CDT Equity issued pre-funded warrants to purchase up to 12,131,770 shares of CDT Equity common stock at an exercise price of $0.0001 per share. The warrants may not be exercised until CDT Equity obtains stockholder approval under Nasdaq rules for issuance of the warrant shares in excess of 19.99% of outstanding common stock. CDT Equity agreed to file a resale registration statement within 60 days of closing to provide registration rights for the warrant shares.

## Terms
- Counterparty: Stockholders of Sarborg Limited · Consideration: stock · Stake: 4.76% · Price/share: $0.0001

## Key dates
- Announced 2026-07-31

## Timeline
- 2026-07-31 · 8-K (0001493152-26-035682): 8-K - CDT Equity Inc. — *CDT Equity Inc. is a Delaware corporation engaged in acquiring equity interests in other companies; it previously operated as Conduit Pharmaceuticals Inc. and Murphy Canyon Acquisition Corp.* On July 30, 2026, CDT Equity Inc. entered into a Securities Purchase Agreement with stockholders of Sarborg Limited (a Cayman Islands company) to acquire 270 shares of Sarborg, representing approximately 4.76% of Sarborg's outstanding common stock. In exchange, CDT Equity issued pre-funded warrants to purchase up to 12,131,770 shares of CDT Equity common stock at an exercise price of $0.0001 per share. The warrants may not be exercised until CDT Equity obtains stockholder approval under Nasdaq rules for issuance of the warrant shares in excess of 19.99% of outstanding common stock. CDT Equity agreed to file a resale registration statement within 60 days of closing to provide registration rights for the warrant shares.
  https://www.sec.gov/Archives/edgar/data/1896212/0001493152-26-035682.txt

## Citations
- 0001493152-26-035682 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000149315226035682